MUCIN-LIKE CANCER-ASSOCIATED ANTIGEN (MCA) COMPARED WITH CA 15-3 IN ADVANCED BREAST-CANCER

被引：13
|
作者：
STEGER, GG [1 ]
MADER, R [1 ]
DERFLER, K [1 ]
MOSER, K [1 ]
DITTRICH, C [1 ]
机构：
[1] VIENNA UNIV,MED 1 KLIN,A-1090 VIENNA,AUSTRIA
来源：
KLINISCHE WOCHENSCHRIFT | 1989年 / 67卷 / 16期
关键词：
D O I：
10.1007/BF01725197
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：813 / 817
页数：5
相关论文
共 50 条
  • [21] CA 15-3 AND CARCINOEMBRYONIC ANTIGEN IN THE CLINICAL-EVALUATION OF BREAST-CANCER
    DNISTRIAN, AM
    SCHWARTZ, MK
    GREENBERG, EJ
    SMITH, CA
    SCHWARTZ, DC
    CLINICA CHIMICA ACTA, 1991, 200 (2-3) : 81 - 93
  • [22] SERUM CEA, CA 15-3, AND MCA IN BREAST-CANCER PATIENTS - A CLINICAL-EVALUATION
    REPETTO, L
    ONETTO, M
    GARDIN, G
    COSTANZI, B
    GIUDICI, S
    VITIELLO, E
    MERLINI, L
    NASO, C
    ZANNINI, C
    PAGANUZZI, M
    ROSSO, R
    SANTI, L
    CANCER DETECTION AND PREVENTION, 1993, 17 (03): : 411 - 415
  • [23] CA 15-3 IN BREAST-CANCER - COMPARISON WITH CEA
    MAIGRE, M
    FUMOLEAU, P
    RICOLLEAU, G
    GUILLARD, Y
    CUSSAC, A
    VIGNOUD, J
    AHKONG, V
    SEMAINE DES HOPITAUX, 1988, 64 (01): : 9 - 13
  • [24] CA-15-3, MUCIN-LIKE CARCINOMA-ASSOCIATED ANTIGEN AND TISSUE POLYPEPTIDE-SPECIFIC ANTIGEN - CORRELATION TO DISEASE STATE AND PROGNOSIS IN BREAST-CANCER PATIENTS
    COHEN, AD
    GOPAS, J
    KARPLUS, G
    COHEN, Y
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1995, 31 (2-3): : 155 - 159
  • [25] Lectin nanoparticle assays for detecting breast cancer-associated glycovariants of cancer antigen 15-3 (CA15-3) in human plasma
    Terava, Joonas
    Tiainen, Leena
    Lamminmaki, Urpo
    Kellokumpu-Lehtinen, Pirkko-Liisa
    Pettersson, Kim
    Gidwani, Kamlesh
    PLOS ONE, 2019, 14 (07):
  • [26] THE SIGNIFICANCE OF DETERMINING CA 15-3 IN THE CYTOSOL OF BREAST-CANCER
    KOSIAN, K
    BIEGLMAYER, C
    NEUNTEUFEL, W
    DADAK, C
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1992, 119 (01) : 58 - 60
  • [27] STUDIES ON CA 15-3, A NEW MARKER IN BREAST-CANCER
    DUFFY, MJ
    SHERRY, F
    CLINICAL SCIENCE, 1986, 71 : P28 - P28
  • [28] CEA, CA 15-3 and MCA: Comparative clinical relevance in breast cancer
    Bremer, K
    Micus, S
    Bremer, G
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1255 - 1255
  • [29] Comparison of the clinical relevance of CEA, CA 15-3 and MCA in breast cancer
    Bremer, K
    Micus, S
    Bremer, G
    Eberhard, A
    ONKOLOGIE, 1996, 19 (02): : 170 - 174
  • [30] CEA AND CA 15-3 IN PRIMARY AND RECURRENT BREAST-CANCER
    ODWYER, PJ
    DUFFY, MJ
    OSULLIVAN, F
    MCDERMOTT, E
    LOSTY, P
    OHIGGINS, NJ
    WORLD JOURNAL OF SURGERY, 1990, 14 (05) : 562 - 566
12345